It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
An emerging approach with potential in improving the treatment of neurodegenerative diseases and brain tumors is the use of focused ultrasound (FUS) to bypass the blood–brain barrier (BBB) in a non-invasive and localized manner. A large body of pre-clinical work has paved the way for the gradual clinical implementation of FUS-induced BBB opening. Even though the safety profile of FUS treatments in rodents has been extensively studied, the histological and behavioral effects of clinically relevant BBB opening in large animals are relatively understudied. Here, we examine the histological and behavioral safety profile following localized BBB opening in non-human primates (NHPs), using a neuronavigation-guided clinical system prototype. We show that FUS treatment triggers a short-lived immune response within the targeted region without exacerbating the touch accuracy or reaction time in visual-motor cognitive tasks. Our experiments were designed using a multiple-case-study approach, in order to maximize the acquired data and support translation of the FUS system into human studies. Four NHPs underwent a single session of FUS-mediated BBB opening in the prefrontal cortex. Two NHPs were treated bilaterally at different pressures, sacrificed on day 2 and 18 post-FUS, respectively, and their brains were histologically processed. In separate experiments, two NHPs that were earlier trained in a behavioral task were exposed to FUS unilaterally, and their performance was tracked for at least 3 weeks after BBB opening. An increased microglia density around blood vessels was detected on day 2, but was resolved by day 18. We also detected signs of enhanced immature neuron presence within areas that underwent BBB opening, compared to regions with an intact BBB, confirming previous rodent studies. Logistic regression analysis showed that the NHP cognitive performance did not deteriorate following BBB opening. These preliminary results demonstrate that neuronavigation-guided FUS with a single-element transducer is a non-invasive method capable of reversibly opening the BBB, without substantial histological or behavioral impact in an animal model closely resembling humans. Future work should confirm the observations of this multiple-case-study work across animals, species and tasks.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Columbia University, Department of Biomedical Engineering, New York City, USA (GRID:grid.21729.3f) (ISNI:0000000419368729)
2 Columbia University, Department of Neuroscience, New York City, USA (GRID:grid.21729.3f) (ISNI:0000000419368729)
3 Columbia University, Mortimer B. Zuckerman Mind Brain Behavior Institute, New York City, USA (GRID:grid.21729.3f) (ISNI:0000000419368729)
4 Columbia University, Institute of Comparative Medicine, New York City, USA (GRID:grid.21729.3f) (ISNI:0000000419368729)
5 Columbia University, Department of Neuroscience, New York City, USA (GRID:grid.21729.3f) (ISNI:0000000419368729); Columbia University, Mortimer B. Zuckerman Mind Brain Behavior Institute, New York City, USA (GRID:grid.21729.3f) (ISNI:0000000419368729)
6 Columbia University, Department of Pathology and Cell Biology, New York City, USA (GRID:grid.21729.3f) (ISNI:0000000419368729)
7 Columbia University, Department of Neuroscience, New York City, USA (GRID:grid.21729.3f) (ISNI:0000000419368729); Columbia University, Mortimer B. Zuckerman Mind Brain Behavior Institute, New York City, USA (GRID:grid.21729.3f) (ISNI:0000000419368729); Columbia University, Department of Psychiatry, New York City, USA (GRID:grid.21729.3f) (ISNI:0000000419368729)
8 Columbia University, Department of Biomedical Engineering, New York City, USA (GRID:grid.21729.3f) (ISNI:0000000419368729); Columbia University, Department of Radiology, New York City, USA (GRID:grid.21729.3f) (ISNI:0000000419368729)